AbbVie Inc. Interest Income (Expense), Nonoperating, Net
AbbVie Inc. (ABBV) reported Interest Income (Expense), Nonoperating, Net of -$679.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2026-08-03
- AbbVie Inc. interest income (expense), nonoperating, net for the quarter ending 2026-06-30 was -$679.00M.
- AbbVie Inc. interest income (expense), nonoperating, net for the quarter ending 2026-03-31 was -$645.00M.
- AbbVie Inc. interest income (expense), nonoperating, net for the quarter ending 2025-12-31 was -$655.00M.
- AbbVie Inc. interest income (expense), nonoperating, net for the quarter ending 2025-09-30 was -$667.00M.
- AbbVie Inc. interest income (expense), nonoperating, net for fiscal 2025 was -$2.63B.
- AbbVie Inc. interest income (expense), nonoperating, net for fiscal 2024 was -$2.16B.
- AbbVie Inc. interest income (expense), nonoperating, net for fiscal 2023 was -$1.68B.
- AbbVie Inc. interest income (expense), nonoperating, net for fiscal 2022 was -$2.04B.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$679.00M 10-Q · filed 2026-08-03 | -$1.32B 10-Q · filed 2026-08-03 | -$1.98B derived: sum of 3 quarters · filed 2026-08-03 | -$2.65B derived: sum of 4 quarters · filed 2026-08-03 |
| 2026-03-31 | -$645.00M 10-Q · filed 2026-05-08 | -$1.30B derived: sum of 2 quarters · filed 2026-05-08 | -$1.97B derived: sum of 3 quarters · filed 2026-05-08 | -$2.65B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-12-31 | -$655.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$1.32B derived: sum of 2 quarters · filed 2026-02-20 | -$2.00B derived: sum of 3 quarters · filed 2026-08-03 | -$2.63B 10-K · filed 2026-02-20 |
| 2025-09-30 | -$667.00M 10-Q · filed 2025-11-04 | -$1.34B derived: sum of 2 quarters · filed 2026-08-03 | -$1.97B 10-Q · filed 2025-11-04 | -$2.58B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-06-30 | -$678.00M 10-Q · filed 2026-08-03 | -$1.30B 10-Q · filed 2026-08-03 | -$1.92B derived: sum of 3 quarters · filed 2026-08-03 | -$2.51B derived: sum of 4 quarters · filed 2026-08-03 |
| 2025-03-31 | -$627.00M 10-Q · filed 2026-05-08 | -$1.24B derived: sum of 2 quarters · filed 2026-05-08 | -$1.83B derived: sum of 3 quarters · filed 2026-05-08 | -$2.33B derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$610.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$1.20B derived: sum of 2 quarters · filed 2026-02-20 | -$1.71B derived: sum of 3 quarters · filed 2026-02-20 | -$2.16B 10-K · filed 2026-02-20 |
| 2024-09-30 | -$591.00M 10-Q · filed 2025-11-04 | -$1.10B derived: sum of 2 quarters · filed 2025-11-04 | -$1.55B 10-Q · filed 2025-11-04 | -$1.93B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | -$506.00M 10-Q · filed 2025-08-04 | -$959.00M 10-Q · filed 2025-08-04 | -$1.34B derived: sum of 3 quarters · filed 2026-02-20 | -$1.74B derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | -$453.00M 10-Q · filed 2025-05-09 | -$831.00M derived: sum of 2 quarters · filed 2026-02-20 | -$1.23B derived: sum of 3 quarters · filed 2026-02-20 | -$1.68B derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | -$378.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$776.00M derived: sum of 2 quarters · filed 2026-02-20 | -$1.23B derived: sum of 3 quarters · filed 2026-02-20 | -$1.68B 10-K · filed 2026-02-20 |
| 2023-09-30 | -$398.00M 10-Q · filed 2024-11-04 | -$852.00M derived: sum of 2 quarters · filed 2024-11-04 | -$1.31B 10-Q · filed 2024-11-04 | -$1.78B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-06-30 | -$454.00M 10-Q · filed 2024-08-07 | -$908.00M 10-Q · filed 2024-08-07 | -$1.38B derived: sum of 3 quarters · filed 2025-02-14 | -$1.88B derived: sum of 4 quarters · filed 2025-02-14 |
| 2023-03-31 | -$454.00M 10-Q · filed 2024-05-03 | -$930.00M derived: sum of 2 quarters · filed 2025-02-14 | -$1.43B derived: sum of 3 quarters · filed 2025-02-14 | -$1.96B derived: sum of 4 quarters · filed 2025-02-14 |
| 2022-12-31 | -$476.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | -$973.00M derived: sum of 2 quarters · filed 2025-02-14 | -$1.50B derived: sum of 3 quarters · filed 2025-02-14 | -$2.04B 10-K · filed 2025-02-14 |
| 2022-09-30 | -$497.00M 10-Q · filed 2023-11-06 | -$1.03B derived: sum of 2 quarters · filed 2023-11-06 | -$1.57B 10-Q · filed 2023-11-06 | -$2.14B derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-06-30 | -$532.00M 10-Q · filed 2023-08-07 | -$1.07B 10-Q · filed 2023-08-07 | -$1.64B derived: sum of 3 quarters · filed 2024-02-20 | -$2.23B derived: sum of 4 quarters · filed 2024-02-20 |
| 2022-03-31 | -$539.00M 10-Q · filed 2023-05-05 | -$1.11B derived: sum of 2 quarters · filed 2024-02-20 | -$1.70B derived: sum of 3 quarters · filed 2024-02-20 | -$2.30B derived: sum of 4 quarters · filed 2024-02-20 |
| 2021-12-31 | -$571.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$1.16B derived: sum of 2 quarters · filed 2024-02-20 | -$1.76B derived: sum of 3 quarters · filed 2024-02-20 | -$2.38B 10-K · filed 2024-02-20 |
| 2021-09-30 | -$585.00M 10-Q · filed 2022-11-04 | -$1.19B derived: sum of 2 quarters · filed 2022-11-04 | -$1.81B 10-Q · filed 2022-11-04 | -$2.43B derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-06-30 | -$606.00M 10-Q · filed 2022-08-04 | -$1.23B 10-Q · filed 2022-08-04 | -$1.85B derived: sum of 3 quarters · filed 2023-02-17 | -$2.47B derived: sum of 4 quarters · filed 2023-02-17 |
| 2021-03-31 | -$622.00M 10-Q · filed 2022-05-06 | -$1.24B derived: sum of 2 quarters · filed 2023-02-17 | -$1.86B derived: sum of 3 quarters · filed 2023-02-17 | -$2.47B derived: sum of 4 quarters · filed 2023-02-17 |
| 2020-12-31 | -$618.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-17 | -$1.24B derived: sum of 2 quarters · filed 2023-02-17 | -$1.85B derived: sum of 3 quarters · filed 2023-02-17 | -$2.28B 10-K · filed 2023-02-17 |
| 2020-09-30 | -$620.00M 10-Q · filed 2021-11-02 | -$1.23B derived: sum of 2 quarters · filed 2021-11-02 | -$1.66B 10-Q · filed 2021-11-02 | -$2.12B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-06-30 | -$614.00M 10-Q · filed 2021-08-02 | -$1.04B 10-Q · filed 2021-08-02 | -$1.50B derived: sum of 3 quarters · filed 2022-02-18 | -$1.92B derived: sum of 4 quarters · filed 2022-02-18 |
| 2020-03-31 | -$428.00M 10-Q · filed 2021-05-07 | -$883.00M derived: sum of 2 quarters · filed 2022-02-18 | -$1.30B derived: sum of 3 quarters · filed 2022-02-18 | -$1.61B derived: sum of 4 quarters · filed 2022-02-18 |
| 2019-12-31 | -$455.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | -$875.00M derived: sum of 2 quarters · filed 2022-02-18 | -$1.18B derived: sum of 3 quarters · filed 2022-02-18 | -$1.51B 10-K · filed 2022-02-18 |
| 2019-09-30 | -$420.00M 10-Q · filed 2020-11-04 | -$729.00M derived: sum of 2 quarters · filed 2020-11-04 | -$1.05B 10-Q · filed 2020-11-04 | -$1.37B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-06-30 | -$309.00M 10-Q · filed 2020-08-04 | -$634.00M 10-Q · filed 2020-08-04 | -$953.00M derived: sum of 3 quarters · filed 2021-02-19 | -$1.25B derived: sum of 4 quarters · filed 2021-02-19 |
| 2019-03-31 | -$325.00M 10-Q · filed 2020-05-08 | -$644.00M derived: sum of 2 quarters · filed 2021-02-19 | -$946.00M derived: sum of 3 quarters · filed 2021-02-19 | -$1.22B derived: sum of 4 quarters · filed 2021-02-19 |
| 2018-12-31 | -$319.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$621.00M derived: sum of 2 quarters · filed 2021-02-19 | -$893.00M derived: sum of 3 quarters · filed 2021-02-19 | -$1.14B 10-K · filed 2021-02-19 |
| 2018-09-30 | -$302.00M 10-Q · filed 2019-11-06 | -$574.00M derived: sum of 2 quarters · filed 2019-11-06 | -$825.00M 10-Q · filed 2019-11-06 | -$1.08B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-06-30 | -$272.00M 10-Q · filed 2019-08-05 | -$523.00M 10-Q · filed 2019-08-05 | -$775.00M derived: sum of 3 quarters · filed 2020-02-21 | -$1.03B derived: sum of 4 quarters · filed 2020-02-21 |
| 2018-03-31 | -$251.00M 10-Q · filed 2019-05-03 | -$503.00M derived: sum of 2 quarters · filed 2020-02-21 | -$755.00M derived: sum of 3 quarters · filed 2020-02-21 | -$1.01B derived: sum of 4 quarters · filed 2020-02-21 |
| 2017-12-31 | -$252.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$504.00M derived: sum of 2 quarters · filed 2020-02-21 | -$757.00M derived: sum of 3 quarters · filed 2020-02-21 | -$1.00B 10-K · filed 2020-02-21 |
| 2017-09-30 | -$252.00M 10-Q · filed 2018-11-07 | -$505.00M derived: sum of 2 quarters · filed 2018-11-07 | -$752.00M 10-Q · filed 2018-11-07 | -$1.04B derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$253.00M 10-Q · filed 2018-08-07 | -$500.00M 10-Q · filed 2018-08-07 | -$790.00M derived: sum of 3 quarters · filed 2019-02-27 | -$1.04B derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | -$247.00M 10-Q · filed 2018-05-04 | -$537.00M derived: sum of 2 quarters · filed 2019-02-27 | -$787.00M derived: sum of 3 quarters · filed 2019-02-27 | -$1.01B derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | -$290.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | -$540.00M derived: sum of 2 quarters · filed 2019-02-27 | -$765.00M derived: sum of 3 quarters · filed 2019-02-27 | -$965.00M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$250.00M 10-Q · filed 2017-11-07 | -$475.00M derived: sum of 2 quarters · filed 2017-11-07 | -$675.00M 10-Q · filed 2017-11-07 | -$874.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-06-30 | -$225.00M 10-Q · filed 2017-08-07 | -$425.00M 10-Q · filed 2017-08-07 | -$624.00M derived: sum of 3 quarters · filed 2018-02-16 | -$821.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2016-03-31 | -$200.00M 10-Q · filed 2017-05-05 | -$399.00M derived: sum of 2 quarters · filed 2018-02-16 | -$596.00M derived: sum of 3 quarters · filed 2018-02-16 | -$760.00M derived: sum of 4 quarters · filed 2018-02-16 |
| 2015-12-31 | -$199.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-16 | -$396.00M derived: sum of 2 quarters · filed 2018-02-16 | -$560.00M derived: sum of 3 quarters · filed 2018-02-16 | -$686.00M 10-K · filed 2018-02-16 |
| 2015-09-30 | -$197.00M 10-Q · filed 2016-11-07 | -$361.00M derived: sum of 2 quarters · filed 2016-11-07 | -$487.00M 10-Q · filed 2016-11-07 | -$616.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-06-30 | -$164.00M 10-Q · filed 2016-08-05 | -$290.00M 10-Q · filed 2016-08-05 | -$419.00M derived: sum of 3 quarters · filed 2017-02-17 | -$547.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2015-03-31 | -$126.00M 10-Q · filed 2016-05-06 | -$255.00M derived: sum of 2 quarters · filed 2017-02-17 | -$383.00M derived: sum of 3 quarters · filed 2017-02-17 | -$452.00M derived: sum of 4 quarters · filed 2017-02-17 |
| 2014-12-31 | -$129.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$257.00M derived: sum of 2 quarters · filed 2017-02-17 | -$326.00M derived: sum of 3 quarters · filed 2017-02-17 | -$391.00M 10-K · filed 2017-02-17 |
| 2014-09-30 | -$128.00M 10-Q · filed 2015-11-06 | -$197.00M derived: sum of 2 quarters · filed 2015-11-06 | -$262.00M 10-Q · filed 2015-11-06 | -$330.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | -$69.00M 10-Q · filed 2015-08-07 | -$134.00M 10-Q · filed 2015-08-07 | -$202.00M derived: sum of 3 quarters · filed 2016-02-19 | -$271.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | -$65.00M 10-Q · filed 2015-05-08 | -$133.00M derived: sum of 2 quarters · filed 2016-02-19 | -$202.00M derived: sum of 3 quarters · filed 2016-02-19 | -$277.00M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | -$68.00M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$137.00M derived: sum of 2 quarters · filed 2016-02-19 | -$212.00M derived: sum of 3 quarters · filed 2016-02-19 | -$278.00M 10-K · filed 2016-02-19 |
| 2013-09-30 | -$69.00M 10-Q · filed 2014-11-07 | -$144.00M derived: sum of 2 quarters · filed 2014-11-07 | -$210.00M 10-Q · filed 2014-11-07 | -$298.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-06-30 | -$75.00M 10-Q · filed 2014-08-07 | -$141.00M 10-Q · filed 2014-08-07 | -$229.00M derived: sum of 3 quarters · filed 2015-02-20 | -$228.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2013-03-31 | -$66.00M 10-Q · filed 2014-05-09 | -$154.00M derived: sum of 2 quarters · filed 2015-02-20 | -$153.00M derived: sum of 3 quarters · filed 2015-02-20 | -$151.00M derived: sum of 4 quarters · filed 2015-02-20 |
| 2012-12-31 | -$88.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | -$87.00M derived: sum of 2 quarters · filed 2015-02-20 | -$85.00M derived: sum of 3 quarters · filed 2015-02-20 | -$84.00M 10-K · filed 2015-02-20 |
| 2012-09-30 | $1.00M 10-Q · filed 2013-11-12 | $3.00M derived: sum of 2 quarters · filed 2013-11-12 | $4.00M 10-Q · filed 2013-11-12 | |
| 2012-06-30 | $2.00M 10-Q · filed 2013-08-09 | $3.00M 10-Q · filed 2013-08-09 | ||
| 2012-03-31 | $1.00M 10-Q · filed 2013-05-08 | |||
| 2011-12-31 | $20.00M 10-K · filed 2014-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |